Danaher upgraded at Goldman Sachs citing an attractive entry point

Wall Street sign, New York City, USA

mbbirdy

Danaher (NYSE:DHR) traded higher in the premarket on Friday after Goldman Sachs upgraded the life sciences company to Buy from Neutral with a $260 per share target, citing an attractive entry point to own the stock.

The upgrade comes at

Leave a Reply

Your email address will not be published. Required fields are marked *